Blood vessels in the eye leak when their walls become damaged or weakened, allowing fluid, blood, or lipids to seep into surrounding retinal tissue. The most common causes are diabetes, high blood pressure, age-related macular degeneration, and retinal vein blockages. Each condition damages vessel walls through a different mechanism, but the result is similar: fluid accumulates where it shouldn’t be, disrupting the delicate layers of tissue responsible for vision.
How Healthy Eye Vessels Normally Work
The retina, the light-sensitive tissue lining the back of your eye, depends on a dense network of tiny blood vessels for oxygen and nutrients. These vessels are sealed by a protective layer called the blood-retinal barrier, which works like a selective filter. It lets essential molecules through while keeping blood cells and excess fluid out of the retinal tissue. When disease, pressure, or abnormal growth compromises this barrier, leakage begins.
Diabetic Retinopathy
Diabetes is one of the most common reasons blood vessels in the eye start leaking. Persistently high blood sugar damages the walls of retinal capillaries over time, causing tiny balloon-like bulges called microaneurysms to form. These weakened spots are especially prone to leaking fluid and blood into the retina. Research using dye-based imaging shows that microaneurysms with higher internal blood flow leak significantly more than those with lower flow, and the leaked fluid tends to pool into small cyst-like pockets in the surrounding tissue.
As the disease progresses, damaged vessels can close off entirely, starving patches of retina of oxygen. The eye responds by growing new blood vessels, but these replacement vessels are structurally fragile and leak even more readily. This advanced stage, called proliferative diabetic retinopathy, carries a high risk of bleeding directly into the gel-like substance that fills the eyeball (the vitreous). That bleeding causes sudden floaters or a dramatic loss of vision.
High Blood Pressure
Chronically elevated blood pressure forces retinal arteries to narrow and thicken in an attempt to protect downstream tissue. Over time, this remodeling weakens vessel walls. When blood pressure spikes severely, typically above 180/120 mm Hg, the vessels can no longer compensate. The blood-retinal barrier breaks down at the level of tiny precapillary arteries, and blood, lipids, and fluid pour through the compromised walls.
In an acute hypertensive crisis (often above 200/120 mm Hg), the damage escalates rapidly. Flame-shaped hemorrhages appear along the surface of the retina, fatty deposits called hard exudates accumulate as lipids leak out, and fluid collects beneath the retina near the center of vision. The optic nerve itself can swell, a sign called papilledema, with hemorrhages fanning out around the disc. These findings define what clinicians call malignant hypertensive retinopathy and signal that organ damage is occurring in real time.
Age-Related Macular Degeneration
In wet (exudative) age-related macular degeneration, the leaking vessels aren’t ones that were already there. They’re abnormal new vessels that grow from the choroid, the blood-vessel-rich layer beneath the retina, and push up into retinal tissue where they don’t belong. This process is driven largely by a signaling molecule called VEGF, which is overproduced when the retinal support layer begins to deteriorate. VEGF stimulates vessel growth but also directly increases vessel permeability, making these new vessels leaky by design.
Because the abnormal vessels are structurally deficient, lacking proper smooth muscle and elastic support, they constantly ooze fluid and blood into the macula, the part of the retina responsible for sharp central vision. The leaked fluid causes the macula to swell, distorting or blurring the center of whatever you’re looking at. Left untreated, the leaking vessels eventually produce scar tissue that permanently replaces healthy retinal cells. Vitreous hemorrhage from wet AMD carries a particularly poor long-term outlook because of this scarring tendency.
Retinal Vein Occlusion
A retinal vein occlusion occurs when a blood clot or compression blocks one of the veins draining blood away from the retina. With the exit route obstructed, pressure builds behind the blockage. Blood and fluid are forced through the distended vessel walls into the retinal tissue, causing rapid swelling in the macula. The result is often a sudden, painless drop in vision in one eye.
Risk factors overlap heavily with cardiovascular disease: high blood pressure, diabetes, high cholesterol, and glaucoma all increase the likelihood of a vein occlusion. The blockage can affect a single branch vein or the central retinal vein. Central vein occlusions tend to be more severe because they disrupt drainage from the entire retina rather than just one quadrant.
Symptoms of Leaking Blood Vessels
The symptoms depend on where the leakage occurs and how much fluid or blood escapes, but they typically affect only one eye at a time. Blurry or distorted central vision is the most common complaint, especially when fluid collects in the macula. Straight lines may appear wavy or bent. Floaters, which look like dark spots, threads, or cobwebs drifting across your field of vision, can appear when blood leaks into the vitreous. In more severe cases, you may notice a sudden, significant drop in vision that develops over hours or days. Eye pain or pressure sometimes accompanies severe episodes but is not always present.
Some people experience no symptoms at all in the early stages, particularly with diabetic retinopathy or mild hypertensive changes. The leakage may be happening at a level too small to noticeably affect vision, which is why routine eye exams catch many of these conditions before symptoms appear.
How Leaking Vessels Are Detected
Eye doctors use two primary tools to identify and measure vessel leakage. The first is fluorescein angiography, in which a fluorescent dye is injected into a vein in your arm and photographed as it flows through the retinal vessels. Leaking spots show up as bright areas that grow between early and late images. Doctors grade the leakage as mild or severe based on how much the dye spreads.
The second tool is optical coherence tomography (OCT), which uses light waves to create cross-sectional images of the retina. OCT excels at showing fluid pockets, swelling, and structural changes in retinal layers. A newer version, OCT with blood flow overlay, can estimate how much flow is passing through individual microaneurysms, offering a noninvasive way to predict which vessels are most likely to leak. One limitation of standard OCT angiography is that it cannot directly visualize leakage the way a dye test can, so the two techniques are often used together.
Treatment for Leaking Vessels
For conditions driven by VEGF, such as wet macular degeneration and the swelling caused by retinal vein occlusion, injections of anti-VEGF medication directly into the eye are the standard treatment. These drugs block the signaling molecule responsible for both abnormal vessel growth and increased permeability. In clinical trials for retinal vein occlusion, roughly 77 to 86 percent of patients treated with anti-VEGF injections achieved normal retinal thickness within 12 months, depending on the type and location of the blockage. In real-world practice, the results are somewhat more modest: fewer than 60 percent of patients reached the best visual targets after individual injections, reflecting the messier realities of treatment timing and follow-up outside of controlled studies.
Comparative studies between two widely used anti-VEGF drugs, aflibercept and ranibizumab, show both are effective for maintaining good visual acuity in macular degeneration, with some evidence that outcomes improve when treatment continues over a longer period. Newer dosing regimens using higher-concentration formulations aim to extend the interval between injections, reducing the burden of frequent office visits.
For diabetic retinopathy, anti-VEGF injections also reduce macular swelling, and laser treatment can be used to seal off leaking vessels or destroy oxygen-starved retinal tissue to discourage new vessel growth. Hypertensive retinopathy is managed primarily by bringing blood pressure under control, which allows the damaged vessels to recover. In many cases, the retinal changes of hypertension are reversible once blood pressure is stabilized.
Risks of Untreated Leakage
Leaking blood vessels that go untreated can set off a chain of complications. Persistent fluid in the macula damages photoreceptors over time, leading to permanent central vision loss. Blood that pools in the vitreous can take weeks or months to clear on its own, and while it lingers, it prevents doctors from monitoring or treating the underlying retinal disease, allowing the problem to worsen unchecked.
In proliferative disease, whether from diabetes or vein occlusion, unchecked vessel growth can produce thick fibrous scar tissue on the retinal surface. This scar tissue contracts, pulling the retina away from the back of the eye (tractional retinal detachment). Abnormal vessels can also grow onto the iris and block the eye’s drainage system, causing a painful and vision-threatening form of glaucoma. These complications are far more difficult to treat than the original leakage, which is why early detection and consistent follow-up matter so much for long-term outcomes.